Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Barbara Ann Karmanos Cancer Institute (1)

National Cancer Institute (NCI) (1)

University Health Network, Toronto (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

laboratory biomarker analysis (2)

atezolizumab (1)

berzosertib (1)

bevacizumab (1)

carboplatin (1)

dexamethasone (1)

gemcitabine hydrochloride (1)

pharmacological study (1)

valproic acid (1)

Study Documents

Intervention Type

drug (3)

other (2)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (3)

ovarian endometrioid tumor

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Metastatic Fallopian Tube Carcinoma, Metastatic Ovarian Carcinoma, Metastatic Primary Peritoneal Carcinoma Trial in United

Active, not recruiting

Metastatic Fallopian Tube Carcinoma
+11 more

Berzosertib
+4 more

Phoenix, Arizona
+13 more

Dec 2, 2022

Ovarian Endometrioid Tumor, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Toronto (Atezolizumab, Bevacizumab)

Recruiting

Ovarian Endometrioid Tumor
+3 more

Toronto, Ontario, Canada

Princess Margaret Cancer Centre

Oct 21, 2021

Adnexal Mass, Borderline Ovarian Epithelial Tumor, Ovarian Clear Cell Tumor Trial in Bay City, Detroit (Dexamethasone,

Completed

Adnexal Mass
+6 more

Dexamethasone
+2 more

Bay City, Michigan
+1 more

Aug 12, 2019